BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
Kwong‐Kwok Wong(The University of Texas MD Anderson Cancer Center), David M. Gershenson(The University of Texas MD Anderson Cancer Center)
Cited by 220
Related Papers
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
|Journal of the National Comprehensive Cancer Network|2019|332
Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells
|Oncotarget|2016|46
Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
|Scientific Reports|2020|12